Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies.
Gupta P, Goswami SG, Kumari G, Saravanakumar V, Bhargava N, Rai AB, Singh P, Bhoyar RC, Arvinden VR, Gunda P, Jain S, Narayana VK, Deolankar SC, Prasad TSK, Natarajan VT, Scaria V, Singh S, Ramalingam S. Gupta P, et al. Among authors: ramalingam s. Nat Commun. 2024 Feb 27;15(1):1794. doi: 10.1038/s41467-024-46036-x. Nat Commun. 2024. PMID: 38413594 Free PMC article.
A Simple, Cost-Effective, and Extraction-Free Molecular Diagnostic Test for Sickle Cell Disease Using a Noninvasive Buccal Swab Specimen for a Limited-Resource Setting.
Thakur P, Gupta P, Bhargava N, Soni R, Varma Gottumukkala N, Goswami SG, Kharya G, Saravanakumar V, Gunda P, Jain S, Dass J, Aggarwal M, Ramalingam S. Thakur P, et al. Among authors: ramalingam s. Diagnostics (Basel). 2022 Jul 21;12(7):1765. doi: 10.3390/diagnostics12071765. Diagnostics (Basel). 2022. PMID: 35885667 Free PMC article.
Establishment and characterization of induced pluripotent stem cell line (IGIBi002-A) from a β-thalassemia patient with IVS1-5 mutation by non-integrating reprogramming approach.
Thakur P, Bhargava N, Jaitly S, Gupta P, Kumar Bhattacharya S, Padma G, Kondaveeti S, Jain S, Ramalingam S. Thakur P, et al. Among authors: ramalingam s. Stem Cell Res. 2020 Dec 10;50:102124. doi: 10.1016/j.scr.2020.102124. Online ahead of print. Stem Cell Res. 2020. PMID: 33338925 Free article.
Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.
Sahana S, Sivadas A, Mangla M, Jain A, Bhoyar RC, Pandhare K, Mishra A, Sharma D, Imran M, Senthivel V, Divakar MK, Rophina M, Jolly B, Batra A, Sharma S, Siwach S, Jadhao AG, Palande NV, Jha GN, Ashrafi N, Mishra PK, Vidhya AK, Jain S, Dash D, Kumar NS, Vanlallawma A, Sarma RJ, Chhakchhuak L, Kalyanaraman S, Mahadevan R, Kandasamy S, Devi P, Rajagopal RE, Ramya JE, Devi PN, Bajaj A, Gupta V, Mathew S, Goswami S, Prakash S, Joshi K, Kumla M, Sreedevi S, Gajjar D, Soraisham R, Yadav R, Devi YS, Gupta A, Mukerji M, Ramalingam S, Binukumar BK, Sivasubbu S, Scaria V. Sahana S, et al. Among authors: ramalingam s. Pharmacogenomics. 2021 Jul;22(10):603-618. doi: 10.2217/pgs-2021-0028. Epub 2021 Jun 18. Pharmacogenomics. 2021. PMID: 34142560 Free PMC article.
1,135 results